The Alzheimer’s Drug Discovery Foundation marked ten years of its Annual Fall Symposium and Luncheon “Hope on the Horizon,” raising nearly $10 million for Alzheimer’s research over the past decade. Pamela J. Newman, CEO of PJN Strategies, received The Charles Evans Award from the Alzheimer’s Drug Discovery Foundation (ADDF) at the luncheon, which was held at The Pierre in New York City, November 1. This year’s event welcomed nearly 400 guests and has raised $1.2 million for Alzheimer’s research.
Nine-time Emmy Award winner and longtime ADDF friend and board member, Paula Zahn, returned to host the inspirational event and welcomed guests to the luncheon, noting, “I am honored to have been a part of the annual Hope on the Horizon luncheon for the past ten years. It is encouraging to know there are so many efforts underway to find better ways to…
